Myocardial protection
Showing 1 - 25 of 7,323
Cardioplegia Solution Adverse Reaction Trial in Fayoum (Modified Del Nido Versus Custodiol Cardioplegia)
Recruiting
- Cardioplegia Solution Adverse Reaction
- Modified Del Nido Versus Custodiol Cardioplegia
-
Fayoum, Faiyum Governorate, EgyptFayoum University hospital
Oct 22, 2022
Myocardial Inflammation, Remodeling, Left Ventricle, Remodeling, Vascular Trial in Frankfurt Am Main (Prednisolone, Losartan)
Recruiting
- Myocardial Inflammation
- +4 more
-
Frankfurt Am Main, Hessen, GermanyInstitute for experimental and translational cardiovascular imag
Dec 13, 2022
Bypass Complication, Cardioplegia Solution Adverse Reaction, Endothelial Degeneration Trial in Istanbul (Endocan, E-Selectin,
Active, not recruiting
- Bypass Complication
- +5 more
- Endocan, E-Selectin, TNF-alpha, Total Oxidant and Antioxidant Status
-
Istanbul, TurkeyDr. Siyami Ersek Hospital
Oct 28, 2022
Cardiac Surgery, Cardiopulmonary Bypass Trial in Seoul (Dexmedetomidine, Control)
Recruiting
- Cardiac Surgery
- Cardiopulmonary Bypass
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 24, 2022
Congenital Heart Disease, Heart Valve Disease Trial in Guangzhou (simvastatin)
Recruiting
- Congenital Heart Disease
- Heart Valve Disease
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital, Sun Yat-sen University
Mar 17, 2022
Anesthesia Trial in Cairo (HTK cardioplegia, Cold Cadioplegia)
Recruiting
- Anesthesia
- HTK cardioplegia
- Cold Cadioplegia
-
Cairo, Nasr City, EgyptSamar Soliman
Jan 3, 2022
Congenital Heart Disease in Children, Cardiopulmonary Bypass Trial in Jakarta (Placebo, Dexmedetomidine Hcl 100 Mcg/mL Inj)
Recruiting
- Congenital Heart Disease in Children
- Cardiopulmonary Bypass
- Placebo
- Dexmedetomidine Hcl 100 Mcg/mL Inj
-
Jakarta, IndonesiaNational Cardiovascular Center Harapan Kita Hospital Indonesia
Mar 25, 2022
Hypertrophic Obstructive Cardiomyopathy Trial in Novosibirsk (Esmolol, Placebo)
Recruiting
- Hypertrophic Obstructive Cardiomyopathy
- Esmolol
- Placebo
-
Novosibirsk, Russian FederationE. Meshalkin National Medical Research Center
Oct 6, 2021
Myocardial Reperfusion Injury, Hypoxia, Hyperoxia Trial (Hypoxic-hyperoxic preconditioning, Placebo)
Completed
- Myocardial Reperfusion Injury
- +3 more
- Hypoxic-hyperoxic preconditioning
- Placebo
- (no location specified)
May 6, 2022
Acute Myocardial Infarction Trial in Beijing (IPC+PCI, No IPC)
Completed
- Acute Myocardial Infarction
- IPC+PCI
- No IPC
-
Beijing, Beijing, ChinaPeking University third hospital
Jul 8, 2021
Myocardial Protection Trial in Seoul (TENS (transcutaneous electrical nerve stimulation), sham intervention)
Completed
- Myocardial Protection
- TENS (transcutaneous electrical nerve stimulation)
- sham intervention
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 18, 2021
Ischemic Reperfusion Injury Trial (SMOFlipid, Normal saline 0.9%)
Not yet recruiting
- Ischemic Reperfusion Injury
- SMOFlipid
- Normal saline 0.9%
- (no location specified)
Jul 2, 2021
Cardiac Surgical Procedures, Heart Valve Prosthesis Implantation Trial in Novosibirsk (Phosphocreatine sodium tetrahydrate after
Completed
- Cardiac Surgical Procedures
- Heart Valve Prosthesis Implantation
- Phosphocreatine sodium tetrahydrate after anaesthesia induction
- +7 more
-
Novosibirsk, Russian FederationEvgeny Fominskiy
Jun 28, 2021
Coronary Artery Bypass Surgery Trial (multiport antegrade cardioplegia, Aortic root antegrade cardioplegia)
Completed
- Coronary Artery Bypass Surgery
- multiport antegrade cardioplegia
- Aortic root antegrade cardioplegia
- (no location specified)
Feb 5, 2021
Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
Completed
- Coronary Artery Disease
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 7, 2022
Coronary Artery Bypass, Myocardial Ischemia, Myocardial Infarction Trial in Karlskrona, Linköping, Örebro (Intravenous infusion
Completed
- Coronary Artery Bypass
- +3 more
- Intravenous infusion of saline
- Intravenous glutamate infusion
-
Karlskrona, Sweden
- +2 more
May 21, 2022
Anterior Myocardial Infarction, Heart Failure Trial in China (drug, device, combination product)
Completed
- Anterior Myocardial Infarction
- Heart Failure
- intravenous Placebo
- +3 more
-
Beijing, Beijing, China
- +15 more
Oct 27, 2021
New X-ray Protective Device in Coronary Interventional Therapy
Enrolling by invitation
- Coronary Heart Disease
-
Nanjing, Jiangsu, ChinaFirst Affiliated Hospital of Nanjing Medical University
Feb 2, 2022
Systemic Inflammatory Response Trial in Sudbury (Influenza Vaccine, Placebo)
Completed
- Systemic Inflammatory Response
- Influenza Vaccine
- Placebo
-
Sudbury, Ontario, CanadaHealth Sciences North Research Institute
Jul 28, 2020
Myocardial Protection in Minimally Invasive Mitral Valve Surgery
Completed
- Myocardial Protection
- +2 more
- Aortic clamp
- (no location specified)
Jan 15, 2020
Optimized Cardioprotection Therapy in Obese Subjects With AMI
Unknown status
- Acute Myocardial Infarction
- +3 more
- PCI
-
Xi'an, Shaanxi, ChinaXijing hospital
Sep 25, 2020
Optimized Cardioprotection Therapy in Obese Subjects With CAD
Unknown status
- Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
- +2 more
- PCI
-
Xi'an, Shaanxi, ChinaXijing hospital
Sep 25, 2020
Novel Cardioplegic Formula With MPS® Versus Cardioplexol ® in
Completed
- Heart Attack
- +2 more
- Myocardial protection system (MPS)
- Cardioplexol
-
Basel, SwitzerlandCardiac Surgery Clinic University Hospital Basel
Mar 16, 2020
Coronary Heart Disease, Obesity, Weight Loss Trial in Chicago (Alternate day fasting, Calorie restriction, Control diet)
Completed
- Coronary Heart Disease
- +2 more
- Alternate day fasting
- +2 more
-
Chicago, IllinoisUniversity of Illinois, Chicago
Jul 8, 2020